Compare Cassava Sciences Inc (FLNA) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while State Street Real Estate Select Sector SPDR ETF trades at $45.27. The key difference: State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | XLRE | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.64 | $45.36 |
52-Week Low | $1.09 | $40.01 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
XLRE, the Real Estate Select Sector SPDR ETF, trades at $44.93, up 1.01% on the day, with technical indicators signaling a bullish trend. The ETF has gained approximately 11% year-to-date, defying broader market pressures, as real estate fundamentals show resilience. Recent news highlights its low 0.08% expense ratio and steady 3.4% distribution yield, while technical analysis shows strong buy signals from moving averages and a neutral stance from oscillators.
The outlook for XLRE appears cautiously optimistic, supported by improving REIT fundamentals and a potential turning point in the sector's repricing cycle. Investment opportunities include exposure to a recovering real estate sector with low-cost efficiency, but risks persist from interest rate volatility, inflation pressures, and potential sector-wide pullbacks if bond yields rise further.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
